MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • White Papers
  • DeviceTalks
Home » Abbott, St. Jude Medical re-up ‘cardiovascular alliance’ | Wall Street Beat

Abbott, St. Jude Medical re-up ‘cardiovascular alliance’ | Wall Street Beat

April 23, 2012 By MassDevice staff Leave a Comment

Share
MassDevice.com Wall Street Beat

Abbott (NYSE:ABT) and St. Jude Medical (NYSE:STJ) are renewing and expanding an alliance to co-market their cardiovascular products, including Abbott’s market-leading Xience coronary stent line.

The deal, which extends a pact the companies inked in 2008, also includes St. Jude’s line of cardiac rhythm management, electrophysiology and cardiology products.

Sign up to get our free newsletters delivered straight to your inbox

It will see Abbott and St. Jude jointly promote the other’s product offerings to U.S. hospital customers, according to a press release, and includes a separate agreement giving Abbott U.S. distribution rights for St. Jude’s hybrid Ilumien FFR/OCT platform and its RadiAnalyzer Xpress system.

 Analyst: Thoratec, HeartWare to split the LVAD market
Thoratec (NSDQ:THOR) and HeartWare International (NSDQ:HTWR) are likely to carve out a 50-50 split of the market for left ventricular assist devices, at least for the next few years, according to "a high-volume EU cardiothoracic surgeon" from "1 of the largest LVAD implanting centers worldwide."

Leerink Swann analysts grilled the doc over the state of the LVAD market overseas, according to a research note to investors, coming away with 3 key points:

  1. “International LVAD market growth is poised to continue at a sustainable low-to-mid-teens pace for the next few years"
  2. "Thrombus concerns with HeartWare’s HVAD – which initially arose at last year’s ISHLT meeting – have eased significantly, at least amongst physicians"
  3. "International competitive dynamics appear basically stable with major shifts in market share for THOR/HTWR seemingly unlikely in the near-term, in line with our basically 50%/50% split through 2015"

HTWR shares plunged after concerns over higher blood clot rates surfaced last year, but the physician interviewed by Leerink said the concerns came as a surprise to cardiac surgeons, prompting initial caution that quickly eased, according to the note.

"But after looking at data specific to his center, he found a 3.5%  thrombus rate with HVAD – basically in line with the low-single-digit rate that Thoratec’s HeartMate II has historically generated. And he cited other centers with HVAD thrombus rates in the 3%-5% range,  but ‘never exceeding 5%,’" the researchers wrote. "Still, he did also note that patient selection and post-operative patient management with HVAD played  a meaningful role in driving that lower thrombus rate. With HVAD, patients at his practice receive heparin post-operation vs. none with HeartMate II."
Read more

 Arrhythmia Research releases Q1 prelims
Arrhythmia Research Technology (NYSE:HRT) said it was unable to file its annual report with the SEC by its April 16 deadline "due to an ongoing internal review by the Audit Committee and auditors relating to the adjustments to the calculation of the tax deferred assets in the company’s Canadian subsidiary, RMDDx Corp.," according to a regulatory filing.

Arrhythmia Research said it expects to post preliminary revenues of $24.3 million and net losses of $1.7 million.
Read more

 ETView Medical inks Taiwan distribution deal

ETView Medical (TLV:TLV) inked a 2-year distribution deal with Champ Medics Co. to market its VivaSight airway management platform in Taiwan.
Read more

 DeHaier Medical in Chinese distribution deal with Timesco
Dehaier Medical Systems (NSDQ:DHRM) signed a 3-year distribution pact to sell Timesco of London’s Optima laryngoscope in China.
Read more

 Nephros licences filtration tech from Medica
Nephros (OTC:NEPH) said it signed license & supply deal with Medica for exclusive global rights to sell the Italian company’s Medisulfone ultrafiltration technology.
Read more

 Toshiba’s Vital Images inks MR deal with Olea
Toshiba Medical Systems‘ (TYO:6502) Vital Images subsidiary and Olea Medical are partnering to integrate thin-client advanced neurological MR solutions on Vital Image’s VitreaAdvanced enterprise visualization software.
Read more

 SurgLine launches subsidiary to partner with spine surgeons
SurgLine Internationalsaid it’s formed SurgLine MDC Holdings LLC to pursue "cost containment of surgical implants in the operating room for hospitals and acute surgery centers," structured so that SMDC owns a minimum of 60% of each operating entity.
Read more

 Funding Roundup

  • OrbiMed closes $222M life science VC fund
  • Great Lakes NeuroTechnologies lands $4.5M in grants
  • Delcath closes $20M revolver with Silicon Valley Bank
  • Imricor Medical Systems raises $4.1M for MRI-safe tools

 Analysts’ ups and downs

  • Abiomed (NSDQ:ABMD): Jefferies & Co. boosts price target from $25 to $28, maintains "buy" rating.
  • HeartWare International (NSDQ:HTWR): Zacks reiterates "neutral" rating, $70 price target.
  • Intuitive Surgical (NSDQ:ISRG): Barclays raises from "equal weight" to "overweight;" Zacks rates "#1 rank (strong buy)."
  • Kimberly-Clark (NYSE:KMB): Bank of America reiterates "buy" rating, raises price target from $80 to $84.

With more than 30 speakers, 25 panels and 4 tracks, you can't miss DeviceTalks Minnesota

textadimage On June 4-5, DeviceTalks Minnesota is taking over the Twin Cities medtech industry with one of the most anticipated conferences of the spring.

Join leaders from 3M, Abbott, Bigfoot Biomedical, Boston Scientific, Cardionomic, CMF Solutions, Cyient, Google Mayo Clinic, Medical Alley, Medtronic, NxThera, Opus College, Relievant Medsystems, University of Minnesota, Star Tribune, Smith & Nephew, Spry Health, Zimmer Biomet and many more when you register today.

Use the code "DTWeb" to save 15% on the cost of registration. 

REGISTER TODAY

Filed Under: Cardiac Assist Devices, News Well, Wall Street Beat Tagged With: Abbott, Arrhythmia Research Technology Inc., Cardiac Rhythm Management, Champ Medics Co., Dehaier Medical Systems Ltd., ETView Medical, HeartWare International Inc., Medica SpA, Nephros, Olea Medical, stjudemedical, SurgLine Inc., Thoratec Corp., Timesco of London, Toshiba, Vital Images Inc.

In case you missed it

  • Brainlab releases VersaHD high-res planning algorithm
  • Varian wins FDA nod for Calypso anchored beacon transponder for SBRT therapy
  • Nephros releases preliminary Q1 earnings, raises $3m
  • Olympus inks endoscope image sharing deal with InterSystems
  • FDA approves IDE trial for Urotronic’s drug-coated balloon
  • FDA approves Angel Medical System’s AngelMed Guardian cardiac monitor
  • Curetis launches diagnostic cartridge for urinary tract infection
  • Hologic touts study comparing NovaSure to Minerva’s endometrial ablation device
  • How Minnesota got a Pediatric Device Innovation Consortium
  • 5 medtech stories we missed this week: April 20, 2018
  • FDA OKs Opus breast implant line from Sientra
  • Sollis lands $50m for long-acting pain-relief drug
  • Chinese investor group acquires Esaote
  • GE Healthcare’s sales, profits up in Q1
  • Qiagen wins FDA nod for point-of-care PartoSure test
  • Valeritas taps Glooko’s data management platform for next-gen insulin delivery device
  • Arthrosurface wins FDA nod for OVOMotion shoulder arthroplasty system

RSS From Medical Design & Outsourcing

  • How Minnesota got a Pediatric Device Innovation Consortium
    FDA funds a handful of pediatric device innovation groups around the United States. But Dr. Gwenyth Fischer, director of The Pediatric Device Innovation Consortium at the University of Minnesota, thinks there’s something that sets the seven-year-old group apart. The Minnesota group, Fischer said, is focused not only on funding but on getting doctors and other academics […]
  • Zeiss adds Xradia Context microCT to X-ray portfolio
    Zeiss has launched its new X-ray imaging instrument the Xradia Context microCT, which is a large field-of-view, non-destructive 3D X-ray microcomputed tomography system. The new Zeiss system is a tomographic imaging solution for 3D characterization and inspection needs for a variety of applications. The system allows users to easily adjust the system to enable imaging […]
  • Medtech stories we missed this week: April 20, 2018
    From CHF Solutions’ new Italian distribution deal to Masimo’s CE Mark approval, here are five medtech stories we missed this week but thought were still worth mentioning. 1. CHF Solutions signs Italian distribution deal CHF Solutions announced in an April 17 press release that it has signed a new distribution agreement with TRX Italy to distribute […]
  • FDA OKs Opus breast implant line from Sientra, with Lubrizol manufacturing
    The FDA this week granted a pre-market approval supplement to Sientra (NSDQ:SIEN) for its Opus line of silicone breast implants. The implants are made in Wisconsin by Lubrizol LifeSciences subsidiary Vesta, which inked a contract manufacturing deal with Sientra back in August 2016. Sales of Sientra’s silicone breast implants ground to a halt in the autumn of 2015, when […]
  • Icon and Intel forge partnership for pharmaceutical analytics platform for clinical trials
    Icon and Intel have struck an deal that allows Icon to offer the Intel Pharma Analytics Platform in clinical trials. The financial details of the deal were not disclosed. The Intel platform is an edge-to-cloud artificial intelligence platform that allows clinical data to be remotely monitored while it continuously captures data for study participants who […]
  • OCTANe announces partnership with Small Cap Nation
    Orange County, Calif.–based life sciences accelerator organization OCTANe recently announced a strategic partnership with Small Cap Nation (SCN), a New York City–based financial media content distribution platform. SCN delivers breaking, on-demand news and information related to the domestic and international small-cap sector. It recently opened a Silicon Valley office. “This partnership will open an important source of capital […]
  • Cadence snapped up by private equity firm Kohlberg & Co.
    Officials at high-precision components and finished devices maker Cadence are selling the Staunton, Va.–based company to private equity outfit Kohlberg & Co. Financial terms of the definitive agreement, announced yesterday, were not disclosed. Cadence makes components and devices for advanced surgical and specialty industrial applications. Cadence CEO Alan Connor will continue to lead the company, and […]
  • Turns out graphene can fight bacteria on implants
    Graphene flakes that are arranged like spikes can kill bacteria and stop infections during implant surgery procedures, according to new research from Chalmers University of Technology in Göteborg, Sweden. Bacteria moves around the body in fluids like blood looking for an area to stick to. Once they find a place, the bacteria starts to grow […]
  • How augmented reality and virtual reality devices are boosting medicine
    Augmented reality (AR) and virtual reality (VR) devices have immense disruptive potential, with the capacity to change how the healthcare industry delivers patient care and provider training. These technologies are helping to take medicine outside clinical spaces and will present a wide range of opportunities for innovators as professionals continue to adapt. Tim Jennings,  Custom […]
  • TT Electonics wraps up acquisition of Stadium Group
    TT Electronics (Woking, U.K.) said today that it has completed its purchase of Stadium Group, a Reading, U.K.–based supplier of connectivity products and services, power supplies, human-machine interface (HMI) and electronic assemblies. Financial terms of the deal were not disclosed. Stadium products are used in applications including medical equipment, smart home, industrial robotics and aircraft cabin controls […]
  • Excelitas Technologies touts OmniCure at InPrint Industrial Inkjet Conference
    Excelitas Technologies is touting its OmniCure OV LED curing solutions at this year’s InPrint Industrial Inkjet Conference at The Palmer House Hilton in Chicago, May 1-2. The company will showcase its new OmniCure AC8-HD (high dose) series of UV LED curing systems that offer higher optical power and enhanced performance in the same air-cooled mechanical […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Connect with us on Google PlusGoogle+

Copyright © 2018 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy